# www.bionautlabs.com > AI-optimized mirror of www.bionautlabs.com containing 50 pages totalling 14,592 words of clean markdown content, structured data, and semantic HTML. Original source: https://www.bionautlabs.com/. Last updated: 2026-05-12T21:01:15.075Z. Each page is available as HTML (with JSON-LD structured data) and Markdown (text-only, ideal for LLMs and RAG). ## Homepage - [Bionaut — Precision micro-technology, the future of healthcare.](/site-root.html): We developed microscale robots to deliver biologics or small molecule therapies locally to targeted disease areas to help patients suffering from severe brain disorders., We developed microscale robots to deliver biologics or small molecule therapies locally to targeted disease areas to help patients suffering from severe brain disorders. (317 words) ## Articles & Blog Posts - [privacy-policy/index.html](/privacy-policy/index.html) (1 words) - [team/index.html](/team/index.html) (1 words) - [Newsroom](/newsroom/index.html) (996 words) - [Bionaut Labs Press Releases](/sitemap-xml.html) (3,464 words) - [Bionaut Labs Debuts From Stealth Mode to Accelerate Development of New Precision Treatment Modality for Brain Disorders — Bionaut](/press-release/bionaut-labs-debuts-from-stealth-mode-to-accelerate-development-of-new-precision-treatment-modality-for-brain-disorders.html): Announced its launch backed by $20 million financing led by Khosla Ventures. Other investors in the syndicate included Upfront Ventures, Revolution, BOLD Capital, and Compound. Proceeds from the financing support the advancement of the Company’s lead therapeutic program in glioma through preclinical, Announced its launch backed by $20 million financing led by Khosla Ventures. Other investors in the syndicate included Upfront Ventures, Revolution, BOLD Capital, and Compound. Proceeds from the financing support the advancement of the Company’s lead therapeutic program in glioma through preclinical development, as well as help advance its program in Huntington’s disease. (989 words) - [Pipeline](/pipeline/index.html) (837 words) - [FDA Grants Humanitarian Use Device Designation to Bionaut Labs for Treatment of Dandy Walker Syndrome](/press-release/fda-grants-humanitarian-use-device-designation-to-bionaut-labs-for-treatment-of-dandy-walker-syndrome.html): The U.S. Food and Drug Administration (FDA) has granted the Company humanitarian use device (HUD) designation for BNL-201 for the local treatment of Dandy Walker Syndrome, a rare pediatric neurological disorder., The U.S. Food and Drug Administration (FDA) has granted the Company humanitarian use device (HUD) designation for BNL-201 for the local treatment of Dandy Walker Syndrome, a rare pediatric neurological disorder. (934 words) - [**Microscale wireless Bionauts reach deep locations in the body, safely & precisely.**](/technology/index.html) (568 words) - [Bionaut Labs and Candel Therapeutics Announce Strategic Collaboration in Precision-Targeted Delivery of Oncolytic Viral Immunotherapies](/press-release/bionaut-labs-and-candel-therapeutics-announce-strategic-collaboration-in-precision-targeted-delivery-of-oncolytic-viral-immunotherapies.html): Companies will work on preclinical development of remote-controlled microscale robots to deliver novel oncolytic viral immunotherapies in specific brain tumors, Companies will work on preclinical development of remote-controlled microscale robots to deliver novel oncolytic viral immunotherapies in specific brain tumors (756 words) - [Bionaut Labs Closes $43M in Series B Led by Khosla Ventures to Advance First-in-Class Micro-Robotic Technology and Remove Barriers to Treat Rare and Debilitating Diseases](/press-release/bionaut-labs-closes-43m-in-series-b-led-by-khosla-ventures-to-advance-first-in-class-micro-robotic-technology-and-remove-barriers-to-treat-rare-and-debilitating-diseases.html): Bionaut Labs, the company that uses microscale robots to revolutionize the treatment of central nervous system (CNS) diseases and disorders, today announced $43.2M in a Series B round of financing led by Khosla Ventures, bringing the company’s total financing raised to date to $63.2 million., Bionaut Labs, the company that uses microscale robots to revolutionize the treatment of central nervous system (CNS) diseases and disorders, today announced $43.2M in a Series B round of financing led by Khosla Ventures, bringing the company’s total financing raised to date to $63.2 million. (722 words) - [Updates](/updates/index.html) (514 words) - [Bionaut — Precision micro-technology, the future of healthcare.](/home/index.html): We developed microscale robots to deliver biologics or small molecule therapies locally to targeted disease areas to help patients suffering from severe brain disorders., We developed microscale robots to deliver biologics or small molecule therapies locally to targeted disease areas to help patients suffering from severe brain disorders. (317 words) - [**Our investors share our vision to revolutionize** the future of healthcare with micro-technology](/investors/index.html) (44 words) - [Press Releases](/press-releases/index.html) (391 words) - [Diagnostic, Biological Sensing/Monitoring, Stimulatory — Bionaut](/application/misc/index.html) (123 words) - [Videos](/videos/index.html) (225 words) - [FDA Grants Bionaut Labs Orphan Drug Designation to BNL-101 for the Treatment of Malignant Gliomas in Pediatric and Adult Patients](/press-release/fda-grants-bionaut-labs-orphan-drug-designation-to-bnl-101-for-the-treatment-of-malignant-gliomas-in-pediatric-and-adult-patients.html): The U.S. Food and Drug Administration (FDA) has granted Bionaut Labs orphan drug designation for BNL-101 for the local treatment of all malignant gliomas including diffuse intrinsic pontine glioma in pediatric and adult patients. BNL-101 is a drug-device combination comprised of doxorubicin as the a, The U.S. Food and Drug Administration (FDA) has granted Bionaut Labs orphan drug designation for BNL-101 for the local treatment of all malignant gliomas including diffuse intrinsic pontine glioma in pediatric and adult patients. BNL-101 is a drug-device combination comprised of doxorubicin as the active drug component together with the company’s Bionaut™ microscale robots. (696 words) - [Applications](/applications/index.html) (179 words) - [Why?](/why/index.html): Using only electricity, our technology platform can remove carbon dioxide both directly from the air and from emission sources. This means we can flexibly help our partners achieve their climate targets in the most affordable way., Using only electricity, our technology platform can remove carbon dioxide both directly from the air and from emission sources. This means we can flexibly help our partners achieve their climate targets in the most affordable way. (218 words) - [News — Bionaut](/news/index.html) (103 words) - [Careers](/careers/index.html) (155 words) - [Press Release — Bionaut](/press-release/index.html) (232 words) - [Applications](/application/microsurgical/index.html) (128 words) - [Therapeutic](/application/therapeutic/index.html) (150 words) - [California start-up hopes to send micro-robots into human brains — Bionaut](/news/california-start-up-hopes-to-send-micro-robots-into-human-brains.html): Agence France-Presse, Agence France-Presse (12 words) - [Dandy-Walker Alliance to Collaborate with Bionaut Labs](/press-release/dandy-walker-alliance-to-collaborate-with-bionaut-labs.html): The Dandy-Walker Alliance is collaborating with Bionaut Labs to educate our constituency about an investigational new treatment for obstructive hydrocephalus associated with Dandy-Walker Syndrome., The Dandy-Walker Alliance is collaborating with Bionaut Labs to educate our constituency about an investigational new treatment for obstructive hydrocephalus associated with Dandy-Walker Syndrome. (384 words) - [Bionaut Selected as a Norrsken Impact/100 company — Bionaut](/news/bionaut-selected-as-a-norrsken-impact-100-company/index.html): Our passion and commitment to creating positive change have propelled us to earn a spot as a Norrsken Impact/100 awardee., Our passion and commitment to creating positive change have propelled us to earn a spot as a Norrsken Impact/100 awardee. (161 words) - [Aviad Maizels](/team/aviad-maizels/index.html) (49 words) - [L.A. Inno includes Bionaut Labs in 14 Startups to Watch — Bionaut](/news/bionaut-is-an-la-inno-startup-to-watch-in-2023/index.html): To help us compile this year’s list, we reached out to L.A. and OC venture capitalists, founders and accelerator leaders, along with information from our reporting since L.A. Inno launched. Dive into our 14 Startups to Watch in 2023., To help us compile this year’s list, we reached out to L.A. and OC venture capitalists, founders and accelerator leaders, along with information from our reporting since L.A. Inno launched. Dive into our 14 Startups to Watch in 2023. (68 words) - [California start-up sends tiny robots on voyage into brains — Bionaut](/news/california-start-up-sends-tiny-robots-on-voyage-into-brains.html): Agence France-Presse, Agence France-Presse (12 words) - [Bionaut Labs Profiled On “Hope and Help Happen Here” Podcast](/news/bionaut-labs-profiled-on-hope-and-help-happen-here-podcast.html): Hope and Help Happen Here, Hope and Help Happen Here (13 words) - [Nathalie Cartier-Lacave, MD](/team/nathalie-cartier-lacave/index.html) (121 words) - [Media Kit](/media/index.html) (36 words) - [Newsweek Interview with Michael Shpigelmacher, CEO & Founder Bionaut Labs](/news/newsweek-interview-with-michael-shpigelmacher-ceo-amp-founder-bionaut-labs.html): In five years, Bionaut Labs will hopefully be recognized as a pioneer and a major platform company in the field of remote-controlled micro-robots, potentially as a public entity or a substantial private organization., In five years, Bionaut Labs will hopefully be recognized as a pioneer and a major platform company in the field of remote-controlled micro-robots, potentially as a public entity or a substantial private organization. (92 words) - [Good Day LA Says Bionauts Could Become One of the Biggest Breakthroughs in Medicine — Bionaut](/news/good-day-la-says-bionauts-could-become-one-of-the-biggest-breakthroughs-in-medicine.html): FOX 11: Good Day LA, FOX 11: Good Day LA (129 words) - [SCIENCE FACT: Bionaut Labs targets disease with remote-controlled micro-robots](/news/science-fact-bionaut-labs-targets-disease-with-remote-controlled-micro-robots.html): L.A. Biz, L.A. Biz (12 words) - [Michael Shpigelmacher](/team/michael-shpigelmacher/index.html) (40 words) - [Dr. Eldad Elnekave, MD](/team/eldad-elnekave/index.html) (62 words) - [Alex Shpunt](/team/alex-shpunt/index.html) (31 words) - [Exclusive: Bionaut Labs raises an extension round in preparation for micro-robot clinical trials. — Bionaut](/news/exclusive-bionaut-labs-raises-an-extension-round-in-preparation-for-micro-robot-clinical-trials.html): Bionaut’s raises an extension round, which involved the Mayo Clinic and Gates Ventures, along with existing investors Khosla Ventures, Upfront Ventures, and OurCrowd., Bionaut’s raises an extension round, which involved the Mayo Clinic and Gates Ventures, along with existing investors Khosla Ventures, Upfront Ventures, and OurCrowd. (39 words) - [Bionaut Labs launches with plans to attack brain tumors with tiny, guided robots](/news/bionaut-labs-launches-with-plans-to-attack-brain-tumors-with-tiny-guided-robots.html): Fierce Biotech, Fierce Biotech (16 words) - [Dr. Ehsan Saadat, MD](/team/ehsan-saadat/index.html) (58 words) - [Contact Us](/contact-us/index.html) (42 words) - [This L.A. start-up is building tiny injectable robots to attack tumors — Bionaut](/news/this-la-start-up-is-building-tiny-injectable-robots-to-attack-tumors.html): L.A. Times, L.A. Times (14 words) - [Bahar Sutorius](/team/bahar-sutorius/index.html) (53 words) - [Thank You!](/thank-you/index.html) (18 words) - [FAQ](/faq/index.html) (12 words) - [Samir Kaul](/team/samir-kaul/index.html) (37 words) - [Candel enlists Bionauts for fight against brain cancers, setting stage for delivery of oncolytic viruses using tiny robots — Bionaut](/news/candel-enlists-bionauts-for-fight-against-brain-cancers-setting-stage-for-delivery-of-oncolytic-viruses-using-tiny-robots.html): Fierce Pharma, Fierce Pharma (21 words) ## Resources - [Full Page Index](/index.html): Browse all cached pages with rich metadata - [About This Cache](/content/about.html): Methodology, technical details, and usage guidelines - [XML Sitemap](/content/sitemap.xml): Machine-readable sitemap for crawler discovery - [Robots.txt](/content/robots.txt): Crawler directives